Report Detail
COVID-19 Impact on Global NGS-Based Monitoring and Diagnostic Test Market Size, Status and Forecast 2020-2026
- RnM4088253 |
- 06 July, 2020 |
- Global |
- 129 Pages |
- QYResearch |
- Other
NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.
Market Analysis and Insights: Global NGS-Based Monitoring and Diagnostic Test Market
The global NGS-Based Monitoring and Diagnostic Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NGS-Based Monitoring and Diagnostic Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NGS-Based Monitoring and Diagnostic Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NGS-Based Monitoring and Diagnostic Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NGS-Based Monitoring and Diagnostic Test market.
NGS-Based Monitoring and Diagnostic Test Breakdown Data by Type
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
NGS-Based Monitoring and Diagnostic Test Breakdown Data by Application
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
Based on regional and country-level analysis, the NGS-Based Monitoring and Diagnostic Test market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global NGS-Based Monitoring and Diagnostic Test market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Commercial Assays/Tests
- 1.2.3 Laboratory Developed Tests
- 1.2.4 Direct to Consumer Test
- 1.2.5 Pre-Commercial Tests
- 1.3 Market by Application
- 1.3.1 Global NGS-Based Monitoring and Diagnostic Test Market Share by Application: 2020 VS 2026
- 1.3.2 Out-Patient Clinics/General Practitioners
- 1.3.3 Diagnostic Centers
- 1.3.4 Hospitals
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Executive Summary
- 2.1 Global NGS-Based Monitoring and Diagnostic Test Market Perspective (2015-2026)
- 2.2 Global NGS-Based Monitoring and Diagnostic Test Growth Trends by Regions
- 2.2.1 NGS-Based Monitoring and Diagnostic Test Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 NGS-Based Monitoring and Diagnostic Test Historic Market Share by Regions (2018-2019)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
3 Competition Landscape by Key Players
- 3.1 NGS-Based Monitoring and Diagnostic Test Revenue by Players (2019-2020)
- 3.2 NGS-Based Monitoring and Diagnostic Test Key Players Head office and Area Served
- 3.3 Key Players NGS-Based Monitoring and Diagnostic Test Product/Solution/Service
- 3.4 Date of Enter into NGS-Based Monitoring and Diagnostic Test Market
- 3.5 Key Players NGS-Based Monitoring and Diagnostic Test Funding/Investment Analysis
- 3.6 Global Key Players NGS-Based Monitoring and Diagnostic Test Valuation & Market Capitalization
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (2019-2026)
5 Global NGS-Based Monitoring and Diagnostic Test Market Size by Application (2019-2026)
6 North America
- 6.1 North America NGS-Based Monitoring and Diagnostic Test Market Forecast (2019-2026)
- 6.2 North America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2015-2020)
- 6.3 North America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2015-2020)
- 6.4 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe NGS-Based Monitoring and Diagnostic Test Market Forecast (2019-2026)
- 7.2 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2015-2020)
- 7.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2015-2020)
- 7.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China NGS-Based Monitoring and Diagnostic Test Market Forecast (2019-2026)
- 8.2 China NGS-Based Monitoring and Diagnostic Test Market Size by Type (2015-2020)
- 8.3 China NGS-Based Monitoring and Diagnostic Test Market Size by Application (2015-2020)
- 8.4 China NGS-Based Monitoring and Diagnostic Test Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan NGS-Based Monitoring and Diagnostic Test Market Forecast (2019-2026)
- 9.2 Japan NGS-Based Monitoring and Diagnostic Test Market Size by Type (2015-2020)
- 9.3 Japan NGS-Based Monitoring and Diagnostic Test Market Size by Application (2015-2020)
- 9.4 Japan NGS-Based Monitoring and Diagnostic Test Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Forecast (2019-2026)
- 10.2 Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Size by Type (2015-2020)
- 10.3 Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Size by Application (2015-2020)
- 10.4 Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Agilent Technologies, Inc.
- 11.1.1 Agilent Technologies, Inc. Company Details
- 11.1.2 Agilent Technologies, Inc. Business Overview
- 11.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
- 11.1.4 Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.1.5 Agilent Technologies, Inc. Recent Development
- 11.2 Ancestry.com LLC
- 11.2.1 Ancestry.com LLC Company Details
- 11.2.2 Ancestry.com LLC Business Overview
- 11.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Introduction
- 11.2.4 Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.2.5 Ancestry.com LLC Recent Development
- 11.3 ArcherDX, Inc.
- 11.3.1 ArcherDX, Inc. Company Details
- 11.3.2 ArcherDX, Inc. Business Overview
- 11.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
- 11.3.4 ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.3.5 ArcherDX, Inc. Recent Development
- 11.4 Beijing Genomics Institute (BGI)
- 11.4.1 Beijing Genomics Institute (BGI) Company Details
- 11.4.2 Beijing Genomics Institute (BGI) Business Overview
- 11.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Introduction
- 11.4.4 Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.4.5 Beijing Genomics Institute (BGI) Recent Development
- 11.5 Cancer Genetics, Inc.
- 11.5.1 Cancer Genetics, Inc. Company Details
- 11.5.2 Cancer Genetics, Inc. Business Overview
- 11.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
- 11.5.4 Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.5.5 Cancer Genetics, Inc. Recent Development
- 11.6 CENTOGENE AG
- 11.6.1 CENTOGENE AG Company Details
- 11.6.2 CENTOGENE AG Business Overview
- 11.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Introduction
- 11.6.4 CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.6.5 CENTOGENE AG Recent Development
- 11.7 F. Hoffmann-La Roche Ltd
- 11.7.1 F. Hoffmann-La Roche Ltd Company Details
- 11.7.2 F. Hoffmann-La Roche Ltd Business Overview
- 11.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Introduction
- 11.7.4 F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.7.5 F. Hoffmann-La Roche Ltd Recent Development
- 11.8 GenePath Dx
- 11.8.1 GenePath Dx Company Details
- 11.8.2 GenePath Dx Business Overview
- 11.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Introduction
- 11.8.4 GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.8.5 GenePath Dx Recent Development
- 11.9 Illumina, Inc.
- 11.9.1 Illumina, Inc. Company Details
- 11.9.2 Illumina, Inc. Business Overview
- 11.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
- 11.9.4 Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.9.5 Illumina, Inc. Recent Development
- 11.10 Laboratory Corporation of America Holdings
- 11.10.1 Laboratory Corporation of America Holdings Company Details
- 11.10.2 Laboratory Corporation of America Holdings Business Overview
- 11.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Introduction
- 11.10.4 Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 11.10.5 Laboratory Corporation of America Holdings Recent Development
- 11.11 Myriad Genetics, Inc.
- 10.11.1 Myriad Genetics, Inc. Company Details
- 10.11.2 Myriad Genetics, Inc. Business Overview
- 10.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
- 10.11.4 Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 10.11.5 Myriad Genetics, Inc. Recent Development
- 11.12 QIAGEN N.V.
- 10.12.1 QIAGEN N.V. Company Details
- 10.12.2 QIAGEN N.V. Business Overview
- 10.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Introduction
- 10.12.4 QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 10.12.5 QIAGEN N.V. Recent Development
- 11.13 Quest Diagnostics Incorporated
- 10.13.1 Quest Diagnostics Incorporated Company Details
- 10.13.2 Quest Diagnostics Incorporated Business Overview
- 10.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Introduction
- 10.13.4 Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 10.13.5 Quest Diagnostics Incorporated Recent Development
- 11.14 Siemens Healthineers, Inc.
- 10.14.1 Siemens Healthineers, Inc. Company Details
- 10.14.2 Siemens Healthineers, Inc. Business Overview
- 10.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
- 10.14.4 Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 10.14.5 Siemens Healthineers, Inc. Recent Development
- 11.15 Thermo Fisher Scientific Inc.
- 10.15.1 Thermo Fisher Scientific Inc. Company Details
- 10.15.2 Thermo Fisher Scientific Inc. Business Overview
- 10.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Introduction
- 10.15.4 Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 10.15.5 Thermo Fisher Scientific Inc. Recent Development
- 11.16 HTG Molecular Diagnostics, Inc.
- 10.16.1 HTG Molecular Diagnostics, Inc. Company Details
- 10.16.2 HTG Molecular Diagnostics, Inc. Business Overview
- 10.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
- 10.16.4 HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 10.16.5 HTG Molecular Diagnostics, Inc. Recent Development
- 11.17 Vela Diagnostics Pte. Ltd.
- 10.17.1 Vela Diagnostics Pte. Ltd. Company Details
- 10.17.2 Vela Diagnostics Pte. Ltd. Business Overview
- 10.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Introduction
- 10.17.4 Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2020))
- 10.17.5 Vela Diagnostics Pte. Ltd. Recent Development
12 Market Dynamics
- 12.1 Drivers
- 12.2 Challenges
- 12.3 Porter’s Five Forces Analysis
- 12.4 Market Ecosystem and Value Chain Analysis
13 Key Findings in This Report
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global NGS-Based Monitoring and Diagnostic Test. Industry analysis & Market Report on COVID-19 Impact on Global NGS-Based Monitoring and Diagnostic Test is a syndicated market report, published as COVID-19 Impact on Global NGS-Based Monitoring and Diagnostic Test Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global NGS-Based Monitoring and Diagnostic Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
